Entrar/Registro  
INICIO ENGLISH
 
Enfermedades Infecciosas y Microbiología
   
MENÚ

Contenido por año, Vol. y Num.

Índice de este artículo

Información General

Instrucciones para Autores

Mensajes al Editor

Directorio






>Revistas >Enfermedades Infecciosas y Microbiología >Año 2006, No. 2


Drago SME
Actividades antibacterianas de lactoferrina
Enf Infec Microbiol 2006; 26 (2)

Idioma: Español
Referencias bibliográficas: 44
Paginas: 58-63
Archivo PDF: 134.84 Kb.

[Texto completo - PDF]

RESUMEN

Diversas especies de mamíferos producen lactoferrina, una glicoproteína no hémica de unión a hierro perteneciente a la familia de las transferrinas. La lactoferrina está presente en una variedad de fluidos exocrinos y es particularmente abundante en leche y calostro. La lactoferrina es un componente esencial de los mecanismos innatos de defensa del hospedero, puesto que exhibe diversas actividades antibacterianas y además por su estratégica presencia en las secreciones diseminadas sobre las superficies mucosas que continuamente están expuestas al contacto con bacterias patógenas. La investigación básica de las propiedades antibacterianas de la lactoferrina ha influido en estudios clínicos relacionados con estrategias profilácticas para la prevención de enfermedades bacterianas, así como en el diseño de métodos terapéuticos para el tratamiento de infecciones causadas por bacterias resistentes a antibióticos.


Palabras clave: lactoferrina, defensa innata, agentes antibacterianos, proteínas de unión a hierro.


REFERENCIAS

  1. Baker EN, Baker HM. Molecular Structure, binding properties and dynamics of lactoferrin. Cell Mol Life Sci 2005; 62: 2531-2539

  2. Vorland LH. Lactoferrin: A multifunctional glycoprotein. APMIS 1999; 107: 971-981

  3. Levay PF, Viljoen M. Lactoferrin: A general review. Haematological 1995; 80: 252-267

  4. Mayer L, Waker WA. “Development and physiology of mucosal defense: an Introduction”. In Mucosal Immunology. Elsevier Academic Press, San Diego Calif. USA. Mestecky J, Lamm ME, McGhee JR, Bienenstock J, Mayer L, Strober W (Eds.). Part I, 3O Edition, 2005, cap.1: 5-18

  5. Orsi N. The antimicrobial activity of lactoferrin: current status and perspectives. Biometals 2004; 17: 189-196

  6. Legrand D, Elass E, Carpentier M, Mazurier J. Lactoferrin: a modulator of immune and inflammatory responses. Cell Mol Life Sci 2005; 62: 2549-2559

  7. Reyes-Reyes RE, Manjarrez-Hernández HA, Drago-Serrano ME. El hierro y la virulencia bacteriana. Enf Inf Microbiol 2005; 25: 104-107

  8. Dionysius DA, Grieve PA, Milne JM. Forms of lactoferrin: their antibacterial effect on enterotoxigenic Escherichia coli. J Dairy Sci 1993; 76: 2597-2600

  9. Dial EJ, Hall LR, Serna H, Romero JJ, Fox JG, Lichtenberger LM. Antibiotic properties of bovine lactoferrin on Helicobater pylori. Dig Dis Sci 1998; 43:2750-2756

  10. Goldoni P, Sinibaldi L, Valenti P, Orsi N. Metal complexes of lactoferrin and their effect on the intracellular multiplication of Legionella pneumophila. Biometals 2000;13:15-22

  11. Schaible UE, Collins HL, Priem F, Kaufmann SH. Correction of the iron overload defect in beta-2-microglobulin knockout mice by lactoferrin abolishes their susceptibility to tuberculosis. J Exp Med 2002; 196: 1507-1513

  12. Ogata T, Teraguchi S, Shin K, Kingaku M, Fukuwatari Y, Kawase K, Hayasawa H, Tomita M. The mechanism of in vivo bacteriostasis of bovine lactoferrin. Adv Exp Med Biol 1998; 443: 239-246

  13. Rogan MP, Taggart CC, Green CM, Murphy PC, O´Neill SJ, McElvaney NG. Loss of microbicidal activity and increased formation of biofilm due to a decreased lactoferrin activity in patients with fibrosis cystic. J Infect Dis 2004; 190: 1245-1253

  14. Berlutti F, Ajello M, Bosso P, Morea C, Petrucca A, Antonini G, Valenti P. Both lactoferrin and iron influence aggregation and biofilm formation in Streptococcus mutans. Biometals 2004; 17: 271-278

  15. Sallmann FR, Baveye-Descamps S, Pattus F, Salmon V,Branza N, Spik G, Legrand D. Porins OmpC and PhoE of Escherichia coli as specific cell surface targets of human lactoferrin. Binding characteristics and biological properties. J Biol Chem 1999; 274: 16107-16114

  16. Appelmelk BJ, An YQ, Geerts M, Thijs BG, de Boer HA, MacLaren DM, de Graaff J, Nuijens JH. Lactoferrin is a Lipid A-binding protein. Infect Immun 1994; 62: 2628-2632

  17. Ellison RT, Laforce FM, Giehl TJ, Boose DS, Dunn BE. Lactoferrin and transferrin damage of the Gram negative outer membrane is modulated by Ca2+ and Mg2+. J Gen Microbiol 1990; 136: 1437-1446

  18. Naidu AS, Arnold RR. Lactoferrin interaction with salmonellae potentiates antibiotic susceptibility. Diag Microbiol Infect Dis 1994; 20: 69-75

  19. Ellison RT 3rd, Giehl TJ, La Force FM. Damage of the outer membrane of enteric gram negative bacteria by lactoferrin and transferrin. Infect Immun 1988; 56: 2774-2781

  20. Leitch EC, Willcox MD. Elucidation of the antistaphylococcal action of lactoferrin and lysozyme. J Med Microbiol 1999; 48: 867-871

  21. Ochoa TJ, Noguera Obenza M, Ebel F, Guzmán CA, Gómez HF, Cleary TG. Lactoferrin impairs type III secretory system function in Enteropathogenic Escherichia coli. Infect Immun 2003; 71: 5149-5155

  22. Kawasaki Y, Tazume S, Shimizu K, Matsuzawa H, Dosako S, Isoda H, Tsukiji M, Fujimura R, Muranaka Y, Ishida H. Inhibitory effects of bovine lactoferrin on the adherence of enterotoxigenic Escherichia coli to host cells. Biosci Biotechnol Biochem 2000; 64: 348-354

  23. Nascimento de Araujo A, Giugliano LG. Human milk fractions inhibit the adherence of diffusely adherent Escherichia coli (DAEC) and enteroaggregative E. coli (EAEC) to HeLa cells. FEMS Microbiol Lett 2000; 184: 91-94

  24. Willer EM, Lima R de L, Giugliano LG. In vitro adhesion and invasion inhibition of Shigella dysentariae, Shigella flexneri and Shigella sonnei clinical strains by human milk proteins. BMC Microbiol 2004; 4: 18-24

  25. Teraguchi S, Shin K, Fukuwatari Y, Shimamura. Glycans of bovine lactoferrin function as receptors for the type I fimbrial lectin of Escherichia coli. Infect Immun 1996; 64: 1075-1077

  26. Qiu J, Hendrixson DR, Baker EN, Murphy TF, St GemeJW 3rd, Plaut AG. Human milk lactoferrin inactivates two putative colonization factors expressed by Haemophilus influenzae. Proc Natl Acad Sci USA 1998; 95: 12641-12646

  27. Longhi C, Conte MP, Seganti L, Polidoro M, Alfsen A, Valenti P. Influence of HeLa lactoferrin on the entry process of Escherichia coli HB101 (pRI203) in cells. Med Microbiol Immunol 1993;182:25-35

  28. Gómez HF, Ochoa TJ, Carlin LG, Cleary TG. Human lactoferrin impairs virulence of Shigella flexneri. J Infect Dis 2003;187: 87-95

  29. Lee HY, Park JH, Seok SH, Baek MW, Kim DJ, Lee BH, Kang PD, Kim YS, Park JH. Potential antimicrobial effects of human lactoferrin against oral infection with Listeria monocytogenes in mice. J Med Microbiol 2005; 54: 1049-1054

  30. Ochoa TJ, Clearly TG. Lactoferrin disruption of bacterial type III secretion systems. Biometals 2004; 17: 257-260

  31. Hendrixson DR, Qiu J, Shewry SC, Fink DL, Petty S, Baker EN, Plaut AG, St Geme III JW. Human milk lactoferrin is a serine protease that cleaves Haemophilus surface proteins at arginine-rich sites. Mol Microbiol 2003;47: 607-617

  32. Ohashi A, Murata E, Yamamoto K, Majima E, Sano E, Le QT, Katunuma N. New functions of lactoferrin and β-casein in mammalian milk as cysteine protease inhibitors.Biochem Biophys Res Commun 2003; 306: 98-103

  33. Gifford JL, Hunter HN, Vogel HJ. Lactoferricin: a lactoferrin derived peptide with antimicrobial, antiviral, antitumor and immunological properties. Cell Mol Life Sci 2005; 62: 2588-2598

  34. Dionysius DA, Milne JM. Antibacterial peptides of bovine lactoferrin: purification and characterization. J Dairy Sci 1997; 80: 667-674

  35. Vorland LH, Ulvatne H, Andersen J, Haukland H, Rekdal O, Svendsen JS, Gutteberg TJ. Lactoferricin of bovine origin is more active than lactoferricins of human, murine and caprine origin. Scand J Infect Dis 1998; 30: 513-517

  36. Yamauchi K, Tomita M, Giehl TJ, Ellison III RT. Antibacterial activity of lactoferrin and a pepsin derived lactoferrin peptide fragment. Infect Immun 1993; 61: 719-728

  37. Shin K, Yamauchi K, Teraguchi S, Hayasawa H, Tomita M, Otsuka Y, Yamazaki S. Antibacterial activity of bovine lactoferrin and its peptides against enterohaemorrhagic Escherichia coli O157:H7. Lett Appl Microbiol 1998; 26: 407-411

  38. Chapple DS, Mason DJ, Joannou CL, Odell EW, Gant V, Evans RW. Structure function relationship of bacterial synthetic peptides homologous to a helical surface region on human lactoferrin against Escherichia coli serotype O111 Infect Immun 1998; 66: 2434-2440

  39. Nibbering PH, Ravensbergen E, Welling MM, van Berkel LA, van Berkel PH, Pauwels EK, Nuijens JH. Human lactoferrinand peptides derived from its N terminus are highly effective against infections with antibiotic resistant bacteria. Infect Immun 2001; 69: 1469-1476

  40. Håversen LA, Engberg I, Baltzer L, Dolphin G, Hanson LÅ, Mattsby-Baltzer I. Human lactoferrin and peptides derived from surface exposed helical region reduce experimental Escherichia coli urinary tract infection in mice. Infect Immun 2000; 68: 5816-5823

  41. Di Biase AM, Tinari A, Pietrantoni A, Antonini G, Valenti P, Conte MP, Superti F. Effect of bovine lactoferricin on enteropathogenic Yersinia adhesion and invasion in HEp-2 cells. J Med Microbiol 2004; 53: 407-412

  42. Longhi C, Conte MP, Penta M, Cossu A, Antonini G, Superti F, Seganti L. Lactoferricin influences early events of Listeria monocytogenes infection in THP-1 human macrophages. J Med Microbiol 2004; 53:87-91

  43. Tomita M, Wakabayashi H, Yamauchi K, Teraguchi S, Hayasawa H. Bovine lactoferrin and lactoferricin derived from milk: production and applications. Biochem Cell Biol 2002; 80:109-112

  44. Lonnerdal B. Human milk proteins: key components for the biological activity of human milk. Adv Exp Med Biol 2004; 554:11-25



>Revistas >Enfermedades Infecciosas y Microbiología >Año2006, No. 2
 

· Indice de Publicaciones 
· ligas de Interes 






       
Derechos Resevados 2019